Metabolic Changes Following Conversion From an Anticalcineurin-Based Therapy to an Everolimus-Based One: A Single-Center Experience

Transplantation Proceedings

Volumn 40, Issue 9, 2008, Pages 3265-3269

  Ayala, M ^a   Morales, J ^a   Fierro, A ^a   Herzog, C ^a   Calabran, L ^a   Buckel, E ^a  

^a CLÍNICA LAS CONDES   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; CALCINEURIN INHIBITOR; CALCIUM; CHOLESTEROL; EVEROLIMUS; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHORUS; SERUM ALBUMIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CALCIUM BLOOD LEVEL; CHRONIC ALLOGRAFT NEPHROPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG DOSE TITRATION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GRAFT RECIPIENT; HUMAN; KIDNEY ALLOGRAFT; MAGNESIUM BLOOD LEVEL; MALE; NEPHROTOXICITY; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEINURIA; TREATMENT OUTCOME; UREA NITROGEN BLOOD LEVEL;

AGED; BLOOD PRESSURE; BODY MASS INDEX; BODY WEIGHT; CALCINEURIN; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; PROTEIN KINASES; RETROSPECTIVE STUDIES; SIROLIMUS;

EID: 55749113683     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2008.05.011     Document Type: Article

References (14)

1. Nashan B. Maximizing the clinical outcome with mTOR. Inhibitors in the renal transplant recipient: defining the role of calcineurin inhibitors. Transpl Int 17 (2004) 279
2. Mulay A.V., Hussain N., Fergusson D., et al. Calcineurin inhibitor withdrawal from sirolimus-based therapy in kidney transplantation: a systematic review of randomized trials. Am J Transplant 5 (2005) 1748
3. Sánchez Fructuoso A., Ruiz San Millán J.C., Calvo N., et al. Evaluation of the efficacy and safety of the conversion from a calcineurin inhibitor to an everolimus-based therapy in maintenance renal transplant patients. Transplant Proc 39 (2007) 2148
4. Ruiz J.C., Sánchez A., Rengel M., et al. Use of the new proliferation signal inhibitor everolimus in renal transplant patients in Spain: preliminary results of the EVERODATA registry. Transplant Proc 39 (2007) 2157
5. Knight R.J., and Kahan B.D. The place of sirolimus in kidney transplantation: can we reduce calcineurin inhibitor renal toxicity?. Kidney Int 70 (2006) 994
6. Watson C.J.E., Firth J., Williams P.F., et al. A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal transplantation. Am J Transplant 5 (2005) 2496
7. Singer S.J., Tiernan R., Sullivan E.J., et al. Interstitial pneumonitis associated with sirolimus therapy in renal transplant recipients. N Engl J Med 343 (2000) 225
8. De Simone P., Petrucelli S., Precisi A., et al. Switch to everolimus for sirolimus-induced pneumonitis in a liver transplant recipient-not all proliferation signal inhibitors are the same: a case report. Transplant Proc 39 (2007) 3500
9. Moro J., Almenar L., Martínez-Dolz L., et al. mTOR inhibitors and their secondary effects in cardiac trasplant recipients: a descriptive study. Transplant Proc 39 (2007) 2365
10. Tenderich G., Fuchs U., Zittermann A., et al. Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients. Clin Transplant 21 (2007) 536
11. Morales J., Fierro A., Benavente D., et al. Conversion from a calcineurin inhibitor-based immunosuppressive regimen to everolimus in renal transplant recipients: effect on renal function and proteinuria. Transplant Proc 39 (2007) 59
12. Campistol J.M., Eris J., Oberbauer R., et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol 17 (2006) 581
13. Teutonico A., Schena P.F., Di Paolo S., et al. Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to tacrolimus. J Am Soc Nephrol 16 (2005) 3128
14. Butani L. Investigation of pediatric renal transplant recipients with heavy proteinuria after sirolimus rescue. Transplantation 78 (2004) 1362